New cancer therapy from Türkiye advances in clinical development
A Türkiye-originated oncology drug candidate, RS-0139, has successfully completed its Phase 1 clinical trial, positioning itself as a key milestone in the country’s biotechnology a...
Original Source
Read the full article at Dailysabah →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.